First patient begins FDA-approved sickle cell gene therapy
On Wednesday, Kendric Cromer, a 12-year-old boy from a Washington suburb, became the first person in the world with sickle cell disease to start a commercially approved gene therapy that could cure the disease.For the approximately 20,000 people with sickle cell disease in the United States who qualify for treatment, the start of Kendric's months-long medical journey may offer hope. But it also signals the difficulties patients face when trying a pair of new treatments for sickle cell disease.For a lucky few, like Kendric, treatment could make the life they longed for possible. As a solemn and shy teenager, he had learned that ordinary activities – riding a bicycle, going out on a cold day, playing football – could cause episodes of excruciating pain.“Sickle cell anemia always steals...